Delivery Order SPE2DB22D1106-SPE2DB25FEBW4

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D1106|SPE2DB25FEAV3, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not designated as a set-aside, has a ceiling value of $1,221.35 and covers the delivery of 10,000 unit vials of the drug Pregnyl. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award is for the delivery of PREGNYL 10,000 UNIT VIALS to the Defense Logistics Agency (DLA). The $2,002.37 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, running through November 2026. The IDC enables efficient...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEUS4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 unit vials of the medication Pregnyl, with a ceiling value of $2,388.96 and a completion date of June 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order valued at $1,208.70 for the provision of 4,565,020,276 units of Pregnyl (10,000 unit vials). The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award, valued at $2,388.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pregnyl 10,000 unit vials, a medical product used for various therapeutic purposes. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of PREGNYL 10,000 UNIT VIALS to the Defense Logistics Agency (DLA). The contract, a delivery order valued at $1,368.40, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Firm Fixed Price pricing type and an ultimate completion date of October 28, 2024. This contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 10,000 unit vials of the pharmaceutical product PREGNYL, with a ceiling value of $1,098.56 and a period of performance through April 3, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,569 vials of Pregnyl, a pregnancy hormone medication, with a ceiling value of $6,842.76. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of October 24, 2023. The contract is not set aside and was awarded through full and open competition....
This is a $1,673.64 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,810,855 units of the prescription drug Pregnyl, a human chorionic gonadotropin product used for various medical purposes. The award has a performance period ending on September 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts with...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred seventy dollars to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 10,000 unit vials of PREGNYL to be delivered to a location in Conshohocken, Pennsylvania by October 13, 2023. No set-aside designation was applied to this requirement. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this contract supports the Defense...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEBW4
    Delivery Order

This federal contract award, identified as SPE2DB22D1106|SPE2DB25FEBW4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,209.00, is for the delivery of PREGNYL 10,000 UNIT VIALS, a medical product.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/5/25, 9:51 AM